Aristotle University Of Thessaloniki (AUTH)
Η σημασία της έκφρασης της ενδοθηλιακής συνθετάσης του μονοξειδίου του αζώτου (eNOS) στο γαστρικό βλεννογόνο διαβητικών ασθενών
Abstract
dc:descriptionGastric motility appears to be disturbed in approximately 50% of patients suffering of type 2 diabetes mellitus (DM) for over a decade. Gastrointestinal symptoms in diabetic patients have been attributed to diabetic gastroparesis, traditionally considered to be mainly a part of autonomic neuropathy, and secondary to elevated blood glucose levels. Thus, gastric motility disorders have been mostly studied in diabetic patients, whereas it remains unclear the fact that incidence and severity of gastrointestinal symptoms have not been shown to be correlated to autonomic neuropathy. Furthermore, chronic poor glycemic control and elevated blood glucose levels (>200 mgr/dl) have been demonstrated as independent risk factors for gastrointestinal symptoms in diabetic patients. Some investigators have suggested submucosal blood flow dysfunction in disturbance of gastric defense in diabetic patients. Nitric oxide (NO), a well-known agent with vasorelaxing properties, produced by constitutively expressed nitric oxide synthase (endothelial, eNOS and neuronal, eNOS) is important for normal functioning of the gastric mucosa. NO is critical in maintaining integrity of intracellular tight junctions of gastric epithelium and its most important function is regulation of mucosal hyperaemic response of submucosal capillaries in gastric hostile environment and epithelial rapid restitution. Microangiopathy is a well-known systemic complication of DM; however, dysfunction of vascular relaxation due to defective NO action is also present. The responsible mechanism is not known, yet impaired function of endothelial nitric oxide synthase (eNOS) and reduced NO production due to eNOS under-expression have both implicated. Data from diabetic experimental models have shown that impaired vascular relaxation of gastric submucosal network is probably responsible, at least in part, for gastric mucosa lesions in DM. Furthermore, experimental studies have shown NO overproduction with subsequent angiogenesis as a defense mechanism to gastric injury. Contrary to these experimental data, relative human studies have not been performed. Therefore, the aim of the present study was to evaluate a possible correlation between chronic glycemic control and the presence of diabetic complications (i.e. neuropathy, retinopathy) and eNOS and CD34 (as angiogenic index) expressions in gastric mucosa of diabetic patients and control subjects. In the present study, 50 non smoking dyspeptic patients, 30 diabetic subjects and 20 non-diabetics dyspeptic control patients were included. All subjects, revealed a normally appearing gastric and duodenal mucosa during upper gastrointestinal endoscopy. Biopsy samples were taken from the gastric body and antrum for histology. Diagnosis of Helicobacter pylori (H.pylori) infection was based on rapid urease test and histology representing the practical diagnostic gold standard. Gastritis was scored histologically according to the modified Sydney classification. The eNOS expression level and microvessel density status estimated by CD34 expression were estimated by (low, medium, high) and correlated with median glycosylated haemoglobin of the last three years, neuropathy and histological degree of gastritis. The chi-square test was used for statistical analysis. Significance was set at 0.05. The most important findings and conclusions of this series are the following: • Three main distribution patterns of eNOS immunoreactivity were observed, as also previously described: along the basolateral surface of mucous cells, thus creating a diffuse impression of eNOS expression, in the endothelial cells of mucosal vessels and in cells within gastric glands, located near the basal membrane. • The two groups did not differ regarding gastritis (chronicity, activity, intestinal metaplasia and atrophic gastritis) incidence and distribution (corpus and antrum). Similarly, no differences were observed between patients with good and poor glycemic control, with or without diabetic neuropathy and with or without diabetic retinopathy. • eNOS expression was not correlated with the presence of chronic and active gastritis. • Intensity of eNOS and CD34 expression in the gastric corpus and antrum were significantly correlated (p<0.001). • Both eNOS and CD34 expression were independently correlated with H.pylori infection. • eNOS expression was attenuated in the corpus but not in the antrum of diabetic patients. • Attenuated eNOS expression was correlated with poor glycemic control and diabetic neuropathy but not with diabetic retinopathy. • Helicobacter pylori infection was correlated with eNOS overexpression in the gastric mucosa of control subjects. H. pylori negative diabetic subjects did not differ with H. pylori negative control subjects regarding eNOS expression. H.pylori (+) control subjects exhibited increased eNOS expression comparing with H.pylori (+) diabetic subjects (p=0.010). • CD34 expression was correlated with the degree of inflammation and chronic gastritis. • Reduction of both eNOS and CD34 in the body-but not in the antrum were observed in the patients group than in controls (p=0.023 and 0.156 respectively). • H.pylori infection was correlated with angiogenesis in the antral mucosa in controls but not in the patients. • CD34 attenuated expression was correlated with poor glycemic control and with diabetic neuropathy but not with diabetic retinopathy. In conclusion, NO defective function is implicated in diabetes mellitus pathophysiology. NO, being a critical molecule in mechanisms of autonomic neuropathy and defective gastric hyperaemic response, is probably, at least in part, responsible for the frequently observed gastrointestinal symptoms in diabetic patients.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lazaraki, Georgia
- Λαζαράκη, Γεωργία
Subjects
dc:subject × 14- Μονοξείδιο αζώτου (NO)
- Σακχαρώδης διαβήτης
- Ενδοθηλιακή συνθετάση του μονοξειδίου αζώτου
- Γαστρικός βλεννογόνος
- Δυσπεψία
- Nitric oxide (NO)
- Diabetes mellitus
- Endothelial nitric oxide synthase
- Gastric mucosa
- Dyspepsie
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19325